In addition, the patient's tumour presented MSI-H phenotype only in mononucleotide markers, a feature reported to occur preferentially in tumours associated with MSH6 germline mutations (Verma et al, 1999; Wijnen et al, 1999), and screening for MLH1 and MSH2 mutations was negative. This evidence concerns the gene MSH6 and neoplasm.